Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: COVID-19

How Histology Can Better Communicate with Physicians

Clinical Laboratory, Laboratory Management, People / By Scott Wallask

CEO SUMMARY: When ordering physicians or pathologists take issue with histology processes, it’s a sign that change is needed somewhere along the line. At American Oncology Network, the resulting communication often centers on bringing greater clarity to the doctors as to how samples are handled in ways that affect transport times and the integrity of …

How Histology Can Better Communicate with Physicians Read More »

To access this post, you must purchase The Dark Report.

Enzo Biochem’s Lab Business Sold to Labcorp for $146M

Clinical Laboratory Trends, Lab Marketplace / By Scott Wallask

COMMERCIAL LABORATORY CONSOLIDATION CONTINUES, this time with news earlier this month that New York City-based Enzo Biochem agreed to sell its clinical laboratory business to Labcorp. The deal points to the problem many clinical laboratories have as demand for SARS-CoV-2 testing evaporates, along with the decline in revenue associated with these tests. The price of …

Enzo Biochem’s Lab Business Sold to Labcorp for $146M Read More »

To access this post, you must purchase The Dark Report.

Labcorp: Ascension Deal Will Earn $550 Million in 2023

Clinical Laboratory, Clinical Laboratory Trends, Lab Marketplace, Laboratory Equipment / By Robert Michel

PUBLICLY TRADED LABORATORY COMPANIES OFFERED INSIGHTS into how acquisitions of hospital lab operations and outreach businesses add to their bottom lines, according to recent reports on full-year 2022 and fourth quarter earnings. Last year was a busy one for the billion-dollar lab corporations in terms of acquisitions. These huge laboratory companies are on the prowl …

Labcorp: Ascension Deal Will Earn $550 Million in 2023 Read More »

To access this post, you must purchase The Dark Report.

QuidelOrtho Earns $3.3 Billion in First Year as Combined Firm

In Vitro Diagnostics, IVD/Lab Informatics, Lab Marketplace, Laboratory Equipment / By Robert Michel

IN OUR FEBRUARY 13, 2023, ISSUE OF THE DARK REPORT, we analyzed the 2022 full-year and Q4 earnings of major IVD companies. At the time our prior issue went to press, QuidelOrtho had not yet reported its year-end results. This is the first time that San Diego-based QuidelOrtho released full-year financial results as an integrated …

QuidelOrtho Earns $3.3 Billion in First Year as Combined Firm Read More »

To access this post, you must purchase The Dark Report.

Pandemic Helped Lab with Hospital Leaders

Lab Intelligence, Laboratory Equipment, Laboratory Management, People / By Scott Wallask

CEO SUMMARY: Growth at Atrium Health during the COVID-19 pandemic elevated its clinical laboratory’s profile with medical leaders and health system administrators. What followed was a new spirit of collaboration that led to lab involvement in cost savings efforts, such as improved blood culture collection and better utilization of expensive reference lab testing. ATRIUM HEALTH …

Pandemic Helped Lab with Hospital Leaders Read More »

To access this post, you must purchase The Dark Report.

Public IVD Companies Report Q4, Full-Year 2022 Earnings

In Vitro Diagnostics, IVD/Lab Informatics, Lab Marketplace, Laboratory Equipment / By Robert Michel

YEAR-END AND Q4 EARNINGS REPORTS FROM MAJOR IN VITRO DIAGNOSTICS (IVD) COMPANIES pointed to a welcome sign of core diagnostic business rebounding. That’s the good news for IVD firms. The bad news? All of the SARS-CoV-2 testing revenue that these companies brought in over the last three years—as clinical laboratories and the general public demanded …

Public IVD Companies Report Q4, Full-Year 2022 Earnings Read More »

To access this post, you must purchase The Dark Report.

February 13, 2023, Intelligence: Late-Breaking Lab News

Late Breaking Lab News / By Scott Wallask

Laboratory leaders should prepare now for the end of the federal public health emergency (PHE) for SARS-CoV-2. The White House announced the PHE would cease on May 11. One big change is that patients covered by Medicare, Medicaid, or private insurance may pay higher costs for COVID-19 treatment, including some diagnostic laboratory tests. If patients …

February 13, 2023, Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

Building Collaborations to Deliver More Value

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

Innovative clinical laboratory leaders closely monitoring the financial health of their labs or hospitals will find plenty to chew on in this issue of The Dark Report. The laboratory team at Atrium Health in Charlotte, North Carolina sets the stage with a case study about how the lab team’s interaction with health system administrators and …

Building Collaborations to Deliver More Value Read More »

To access this post, you must purchase The Dark Report.

National Lab Says It Will Help with Supply Chain Services

Clinical Laboratory, Clinical Laboratory Trends, In Vitro Diagnostics, IVD/Lab Informatics, Laboratory Management / By Robert Michel

RECOGNIZING THAT SUPPLY CHAIN ISSUES are troublesome to some of its clinical laboratory customers, one national lab company has announced it would like to help solve those issues. In September, Quest Diagnostics issued a press release describing a novel relationship in which it will act as a supply chain partner for one of its clinical …

National Lab Says It Will Help with Supply Chain Services Read More »

To access this post, you must purchase The Dark Report.

CLIA on Path to Recognize Lab Data As a Specimen

Clinical Laboratory, Clinical Laboratory Trends, Lab Risk & Compliance, Laboratory Compliance / By Scott Wallask

CEO SUMMARY: Discussions within the federal Clinical Laboratory Improvement Advisory Committee (CLIAC) are focusing on digital diagnostic data and clinical laboratory testing conducted remotely. CLIAC recommendations about these important topics may eventually be part of updates to CLIA, whose language has remained largely untouched since its inception in 1988. SWEEPING RECOMMENDATIONS ARE BEFORE FEDERAL CLINICAL …

CLIA on Path to Recognize Lab Data As a Specimen Read More »

To access this post, you must purchase The Dark Report.

;